BCM
TPTX

BCK Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

BCK Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,192
Closed -$1.29M – 110
2022
Q2 		$1.29M Buy
+17,192
New +$764K 1% 33

BCK Capital Management's TPTX Position: Q3 2022 in Review

BCK Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 17,192 shares — an estimated $1.29M sold.

BCK Capital Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.29M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • BCK Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • BCK Capital Management sold 17,192 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.29M.
  • BCK Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • BCK Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.29M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on BCK Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.